Company Profile

Eccrine Systems is structured around development of non-invasive, electronic wearable systems designed explicitly to support measurement and transmission of real-time data about human sweat. From the premise that currrent medication dosing methods and systems are inefficient, ineffective, and potentially toxic, principals of the firm have demonstrated that pharmacokinetics (PK) of a small molecule drug can be measured in locally stimulated sweat and correlates with its pharmacokinetics in blood. From that analysis, the firm is tackling individualizing the prescription of medicine with a breakthrough platform that supports remote, non-invasive, and quantitative medication monitoring through sweat. Having the potential to enable providers to personalize pharmacotherapy across applications ranging from opioid compliance to precision dosing of narrow therapeutic index drugs in oncology and organ transplant, the firm's platform technology enables the right dose of the right drug rapidly and conveniently across multiple applications. Outcomes could enable patient specific dosing, yielding improved clinical outcomes, increased patient adherence, fewer adverse drug reactions and reduced overall cost of healthcare